治疗症状性感染以及毒性和耐药性的共同演变
1Center for Interdisciplinary Research in Biology (CIRB), College de France, CNRS, INSERM, Université PSL, Paris, France.
概括
在症状出现后应用的抗微生物治疗最初可以有利于更为毒性的耐药性感染. 然而,在对药物敏感的感染中,毒性最终被选择为对抗,特别是当治疗率取决于感染严重程度时.
科学领域:
- 进化生物学是进化的生物学.
- 流行病学 流行病学
- 数学建模的数学建模
背景情况:
- 抗菌药物治疗是在症状出现后开始的,通常与感染严重程度相关.
- 感染严重程度,宿主死亡率和化疗易感性之间的相互作用对于理解共同进化动态至关重要.
研究的目的:
- 探索症状发作和感染严重程度之间的联系如何影响毒性和耐药性的共同进化.
- 研究治疗政策对病原体进化轨迹的影响.
主要方法:
- 利用数学流行病学模型来模拟共同进化的动态.
- 采用适应动力学来识别进化稳定策略 (ESS).
主要成果:
- 耐药性感染最初往往更具毒性,尤其是在没有先前存在的耐药性的情况下.
- 随着流行病的进展,病毒性在药物敏感感染中受到更强烈的反选择.
- 随着毒性增加的治疗率通常会导致ESS毒性值降低.
- 长期的进化动态是由特定的遗传权衡和参数值决定的.
结论:
- 流行病学,公共卫生政策和寄生虫进化之间的反循环至关重要.
- 将治疗率与感染毒性联系在一起的政策可以在对药物敏感的感染中有利于较少毒性的菌株.
- 这些发现对监测和管理针对抗微生物药物使用的毒性演变有影响.
相关概念视频
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Antibiotic Selection
53.2K
Overview
53.2K
Viral Mutations
32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


